6/5/2024

Dantrolene Sodium Injection

Products Affected - Description

- Dantrium intravenous lyophilized powder for injection, Par Pharmaceuticals, 20 mg, vial, 6 count, NDC 42023-0123-06
- Dantrolene sodium intravenous lyophilized powder for injection, Hikma, 20 mg, vial, 1 count, NDC 00143-9297-01

Reason for the Shortage

- Eagle has Ryanodex available for drop shipment through wholesalers.
- Hikma did not provide a reason for the shortage.
- Par did not provide a reason for the shortage.
- US Worldmeds has Revonto available for drop shipment through wholesalers.

Available Products

- Revonto intravenous lyophilized powder for injection, US WorldMeds, LLC, 20 mg, vial, 6 count, NDC 78670-0003-67
- Ryanodex intravenous lyophilized powder for injection, Eagle Pharmaceuticals, 250 mg, 20 mL vial, 1 count, NDC 42367-0540-32

Estimated Resupply Dates

- Hikma has dantrolene 20 mg vials on back order and the company estimates a release date of mid-July 2024.
- Par has Dantrium on back order and the company estimates a release date of late-June 2024.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.